Relationship between baseline white blood cell count and renal and hepatic function in older patients with acute myeloid leukemia

Autor: Agnieszka Wierzbowska, Hagop M. Kantarjian, Grzegorz Mazur, Erhan Berrak, Jacques Delaunay, Mark M. Jones, Mark D. Minden
Rok vydání: 2014
Předmět:
Adult
medicine.medical_specialty
ECOG PS
Eastern Cooperative Oncology Group Performance Status

BUN
blood urea nitrogen

Decitabine
AST
aspartate aminotransferase

Gastroenterology
lcsh:RC254-282
Article
CRi
complete response with incomplete blood count recovery

hemic and lymphatic diseases
Internal medicine
White blood cell
ALT
alanine aminotransferase

Post-hoc analysis
medicine
Blood urea nitrogen
AML
acute myeloid leukemia

Acute myeloid leukemia
Leukemia
SC
supportive care

business.industry
PR
partial remission

Myeloid leukemia
Hematology
medicine.disease
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Prognosis
medicine.anatomical_structure
Oncology
Immunology
CR
complete response

Cytarabine
business
medicine.drug
French–American–British classification
FAB
French–American–British classification

WBC
white blood cell
Zdroj: Leukemia Research Reports
Leukemia Research Reports, Vol 3, Iss 1, Pp 17-20 (2014)
ISSN: 2213-0489
DOI: 10.1016/j.lrr.2013.12.001
Popis: Background: In a phase III trial, older patients with acute myeloid leukemia (N=485) received decitabine or treatment choice (supportive care or cytarabine). This post hoc analysis examined whether baseline renal and hepatic function and white blood cell (WBC) counts predicted response. Methods: Baseline WBCs and renal and liver function markers were tabulated for responders/nonresponders. Results: Nonresponders had higher mean baseline creatinine (P=0.005). Creatinine data showed no significant between-group differences by treatment within responder category. Conclusions: No relationship was found between baseline WBCs or hepatic function and response. Higher baseline creatinine in nonresponders may not be clinically relevant.
Databáze: OpenAIRE